The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease. ADNI researchers collect, validate and utilize data such as MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors for the disease. Data from the North American ADNI’s study participants, including Alzheimer’s disease patients, mild cognitive impairment subjects and elderly controls, are available from this site.
New DTI ROI Summary Measures Dataset available
New DTI ROI summary measures are available in the Download section of the ADNI archive....
New ADNI GO/2 MRI QC Data AvailableMore News >
New MRI QC data from the Jack Lab is available in the Download section...